学术搜索
科研智能体
- Research Labs
- AI 阅读
- AI 文库
- AMiner 沉思
- AMiner 亮点
学术资源
- AI2000
- 期刊/会议
- 学者库
- 学术API
- 溯源树
- 数据集
知识沉淀
- 学术空间

订阅小程序

旧版功能

aminer vip

开通会员低至0.73元/天

一次搞定AI科研

立即登录

Peter Mortimer | AMiner学者主页 | AMiner

Peter Mortimer

Takeda Global Res & Dev Ctr Europe Ltd

5Papers / 论文

5Citations / 引用

1H-Index

浏览量10

全面呈现 [Peter Mortimer] 的学术影响力

深度挖掘高质量成果与权威引用，让优秀看得见

研究兴趣

暂无数据

论文（5）

专利

基金项目

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1100 Investigational Single Agent Orteronel (ortl, TAK-700) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer (nmcrpc): Updated Results

M. Hussain,P.G. Corn,D. Michaelson,H.J. Hammers,J.J. Alumkal,C.J. Ryan,J.Y. Bruce,S. Moran,D. Maclean, S-Y. Lee,P. Mortimer,D.J. George

2013European Urology Supplements（2013）

引用

加入学术空间

2124 Activity and Safety of the Investigational Agent Orteronel (ortl, TAK-700) in Men with Nonmetastatic Castration-Resistant Prostate Cancer (CRPC) and Rising Prostate-Specific Antigen (PSA): Results of a Phase 2 Study

M. Hussain,P. Corn,D. Michaelson,H. Hammers,J. Alumkal,C. Ryan,J. Bruce,S. Moran,P. Mortimer, S. Y. Lee,D. George

2012EUROPEAN UROLOGY SUPPLEMENTS（2012）引用：4

引用

加入学术空间

3Safety and Efficacy of the Investigational Agent Orteronel (TAK-700) Without Prednisone in Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) Patients with Rising Prostate-Specific Antigen (PSA): Updated Results from a Phase 2 Study

M. Hussain,P. Corn,D. Michaelson,H. Hammers,J. Alumkal,C. Ryan,J. Bruce,S. Moran,S. Lee, N. Borgstein,I Webb,P. Mortimer,

2012UROLOGY（2012）

引用

加入学术空间

4P115 A Phase 2 Multicenter Study of the Investigational Single Agent Orteronel (ortl, TAK-700) in Nonmetastatic Castration-Resistant Prostate Cancer (nmcrpc) and Rising Prostate-Specific Antigen (PSA)

M. Hussain,P.G. Corn,D. Michaelson,H.J. Hammers,J.J. Alumkal,C.J. Ryan,J.Y. Bruce,S. Moran, S.Y. Lee,P. Mortimer,D.J. George

2012European Urology Supplements引用：1

引用

加入学术空间

5P114 Safety and Efficacy of Orteronel (TAK-700), an Oral, Investigational, Nonsteroidal 17,20-Lyase Inhibitor, with Docetaxel and Prednisone (DP) in Metastatic Castration-Resistant Prostate Cancer (mcrpc): Phase 2 Results from a Phase 1/2 Study

D. Petrylak,J. Gandhi,W.R. Clark,E.I. Heath, J. Lin, W.K. Oh,D.B. Agus,B. Carthon,S. Moran,P. Mortimer, G. Liu

2012European Urology Supplements

引用

加入学术空间

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

Moran Susan

Moran Susan合作论文数5

Daniel James George合作论文数Duke Cancer Institute, Duke University;Center for Prostate & Urologic Cancers, Duke University;Divisions of Medical Oncology and Urology, Duke University School of Medicine4

D Michaelson

D Michaelson合作论文数4

Hans Hammers合作论文数Department of Internal Medicine, UT Southwestern Medical Center;Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center;Division of Hematology and Oncology, UT Southwestern Medical Center4

Joshi Alumkal合作论文数Department of Internal Medicine, University of Michigan3

Charles (Chuck) Ryan合作论文数ZERO Prostate Cancer3

P Corn

P Corn合作论文数2

Paul G. Corn

Paul G. Corn合作论文数2

I Webb

I Webb合作论文数1

J. Gandhi

J. Gandhi合作论文数1

william r clark

william r clark合作论文数1

Justine Bruce合作论文数Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison1

S. Lee

S. Lee合作论文数1

J. Alumkal

J. Alumkal合作论文数1

Daniel P. Petrylak合作论文数Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine;Department of Urology, Yale School of Medicine1

Bradley C. Carthon合作论文数Winship Cancer Institute, Emory University;Department of Hematology and Medical Oncology, School of Medicine, Emory University1

MacLean David

MacLean David合作论文数1

Maha H.A. Hussain合作论文数Feinberg School of Medicine, Northwestern University1

Christopher W Ryan合作论文数Oregon Health and Science University Knight Cancer Institute1

David B. Agus

David B. Agus合作论文数1

Elisabeth Heath合作论文数Department of Oncology, School of Medicine, Wayne State University;Karmanos Cancer Institute, Wayne State University1

Jeffrey N. Bruce

Jeffrey N. Bruce合作论文数1

相似学者

Daniel James George

Charles (Chuck) Ryan

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn